JP2015522592A5 - - Google Patents

Download PDF

Info

Publication number
JP2015522592A5
JP2015522592A5 JP2015521985A JP2015521985A JP2015522592A5 JP 2015522592 A5 JP2015522592 A5 JP 2015522592A5 JP 2015521985 A JP2015521985 A JP 2015521985A JP 2015521985 A JP2015521985 A JP 2015521985A JP 2015522592 A5 JP2015522592 A5 JP 2015522592A5
Authority
JP
Japan
Prior art keywords
compound
formula
pharmaceutical composition
composition according
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015521985A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015522592A (ja
JP6229717B2 (ja
Filing date
Publication date
Priority claimed from EP20120176726 external-priority patent/EP2687528A1/en
Application filed filed Critical
Publication of JP2015522592A publication Critical patent/JP2015522592A/ja
Publication of JP2015522592A5 publication Critical patent/JP2015522592A5/ja
Application granted granted Critical
Publication of JP6229717B2 publication Critical patent/JP6229717B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015521985A 2012-07-17 2013-06-14 ガンマセクレターゼモジュレーターとしての縮合トリアゾール誘導体 Active JP6229717B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261672436P 2012-07-17 2012-07-17
EP12176726.3 2012-07-17
EP20120176726 EP2687528A1 (en) 2012-07-17 2012-07-17 Fused triazole derivatives as gamma secretase modulators
US61/672,436 2012-07-17
PCT/EP2013/001774 WO2014012614A1 (en) 2012-07-17 2013-06-14 Fused triazole derivatives as gamma secretase modulators

Publications (3)

Publication Number Publication Date
JP2015522592A JP2015522592A (ja) 2015-08-06
JP2015522592A5 true JP2015522592A5 (enExample) 2017-01-05
JP6229717B2 JP6229717B2 (ja) 2017-11-15

Family

ID=46514224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015521985A Active JP6229717B2 (ja) 2012-07-17 2013-06-14 ガンマセクレターゼモジュレーターとしての縮合トリアゾール誘導体

Country Status (8)

Country Link
US (1) US9527853B2 (enExample)
EP (2) EP2687528A1 (enExample)
JP (1) JP6229717B2 (enExample)
CN (1) CN104640859B (enExample)
AU (1) AU2013292782B2 (enExample)
CA (1) CA2879195C (enExample)
ES (1) ES2617241T3 (enExample)
WO (1) WO2014012614A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107108581B (zh) * 2014-08-21 2020-06-23 百时美施贵宝公司 作为强效rock抑制剂的回接苯甲酰胺衍生物
WO2017042114A1 (en) * 2015-09-09 2017-03-16 F. Hoffmann-La Roche Ag Bridged piperidine derivatives
CN109311878B (zh) * 2016-06-27 2022-05-24 豪夫迈·罗氏有限公司 作为γ-分泌酶调节剂的三唑并吡啶类化合物
JP6980751B2 (ja) * 2016-07-14 2021-12-15 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 縮合ピリミジン誘導体
EP3523304B1 (en) * 2016-10-04 2021-01-27 H. Hoffnabb-La Roche Ag Bicyclic heteroaryl derivatives
CN107200737B (zh) * 2017-06-29 2019-03-26 武汉药明康德新药开发有限公司 叔丁氧羰基-3-(羟甲基)-[1,2,3]三氮唑[1,5-a]哌啶-6-酰胺制法
CN116925024B (zh) * 2023-07-24 2025-07-25 阜阳欣奕华制药科技有限公司 一种4,6-二甲基阔马酸甲酯的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035313A1 (es) 1999-01-27 2004-05-12 Wyeth Corp Inhibidores de tace acetilenicos de acido hidroxamico de sulfonamida a base de alfa-aminoacidos, composiciones farmaceuticas y el uso de los mismos para la manufactura de medicamentos.
AU5702201A (en) 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
CN102584813B (zh) * 2003-05-14 2016-07-06 Ngc药物公司 化合物及其在调节淀粉样蛋白β中的用途
TWI378091B (en) * 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
GEP20115139B (en) * 2006-03-09 2011-01-10 Eisai R&D Man Co Ltd Polycyclic cinnamide derivative
CN101848897A (zh) 2007-09-06 2010-09-29 先灵公司 γ分泌酶调节剂
MX2010006243A (es) * 2007-12-06 2010-08-31 Schering Corp Moduladores de gamma secretasa.
JP2011506445A (ja) * 2007-12-13 2011-03-03 アムジエン・インコーポレーテツド γ−セクレターゼ調節剤
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) * 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
RU2515976C2 (ru) * 2009-02-26 2014-05-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Азотсодержащие конденсированные гетероциклические соединения и их применение в качестве ингибиторов продукции бета-амилоида
US20120142672A1 (en) * 2009-07-13 2012-06-07 Tatsuki Koike Heterocyclic compound and use thereof
PH12012501381A1 (en) 2010-01-15 2012-10-22 Janssen Pharmaceuticals Inc Novel substituted bicyclic triazole derivatives as gamma secretase modulators
US20110190269A1 (en) * 2010-02-01 2011-08-04 Karlheinz Baumann Gamma secretase modulators
UY33586A (es) * 2010-09-02 2012-03-30 Takeda Pharmaceutical Compuesto heterocíclico y sus usos

Similar Documents

Publication Publication Date Title
JP2009542716A5 (enExample)
JP2019524883A5 (enExample)
JP2012513416A5 (enExample)
JP2016515561A5 (enExample)
JP2017511360A5 (enExample)
JP2014508804A5 (enExample)
JP2010523522A5 (enExample)
JP2016517857A5 (enExample)
JP2016516043A5 (enExample)
JP2014511892A5 (enExample)
JP2016540742A5 (enExample)
JP2015509535A5 (enExample)
JP2016509047A5 (enExample)
JP2014114295A5 (enExample)
JP2019515908A5 (enExample)
RU2016134751A (ru) Соединения
JP2018534286A5 (enExample)
JP2016507502A5 (enExample)
JP2018531987A5 (enExample)
JP2018523689A5 (enExample)
JP2019516739A5 (enExample)
JP2016513696A5 (enExample)
JP2016539157A5 (enExample)
JP2016531950A5 (ja) 複素環化合物
JP2015172098A5 (enExample)